🇺🇸 FDA
Patent

US 11976100

Methods for treating myelin associated diseases and mitochondria associated diseases

granted A61KA61K38/00A61K38/1709

Quick answer

US patent 11976100 (Methods for treating myelin associated diseases and mitochondria associated diseases) held by Larimar Therapeutics, Inc. expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Larimar Therapeutics, Inc.
Grant date
Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61K38/1709, A61P, A61P25/28